In non-small cell lung cancer (NSCLC), exosomal lncRNA SOX2 overlapping transcript (SOX2-OT) secreted from NSCLC cells boosts M2 polarization, thus increasing EGFR-TKI resistance by targeting the miR-627-3p/SMADs pathway [72]. Here, EGFR is linked to non-small cell lung carcinoma.